CEO
Spearheaded the commercialization of a new corneal wound healing contact lens, treating over 1,000,000 patients and securing early-stage financing.
Director, Marketing and Sales
With 30 years in ophthalmic devices and pharmaceuticals, he introduced glaucoma shunts and amniotic membrane technologies to the US market.
CMO
An expert of the diagnosis and treatment of macular degeneration, glaucoma, and diabetes, Dr. Gelb is experienced in the evaluation and fitting of specialty contact lenses.